ANTHONY VITA: Open Payments
NPI 1811148380 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 6 payments from 6 companies in 2025. Trend: 2023 $165 · 2024 $33 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| ABBVIE INC. | 1 | $25 |
| Bausch Health US, LLC | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $15 |
Products named: FANAPT, VRAYLAR, APLENZIN, REXULTI, AUSTEDO XR, Dyanavel XR.
Industry payments across UT — which companies pay providers there.
